EMED is pleased to announce that all of the Resolutions proposed at the Company’s Extraordinary General Meeting, held at 12.00 p.m. (London time) today, passed. Admission to trading on AIM of the New Ordinary Shares, following the Consolidation of the Existing Ordinary Shares is expected to commence at 08:00 a.m. (BST) on 21 October 2015.
Alberto Lavandeira, CEO of the Company, commented: “We are delighted with our shareholders’ continued support as the Company achieves significant milestones while we work towards restarting production. We look forward to further developing our operations as we increase the scale of production and in time, the potential reach of our operations.”
Capitalised terms in this announcement, unless otherwise defined, have the same meaning given to them as in the announcement issued by the Company on 11 September 2015.
Download full announcement:EGM_results_announcement_13_10_15